Chapter 1. Pharmaceutical Amino Acid Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Pharmaceutical Amino Acid Market – Executive Summary
2.1 Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Pharmaceutical Amino Acid Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Pharmaceutical Amino Acid Market Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Pharmaceutical Amino Acid Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Pharmaceutical Amino Acid Market – By source
6.1 Introduction/Key Findings
6.2 Plant-based Amino acid
6.3 Animal-based Amino acid
6.4 Chemical synthesis
6.5 Y-O-Y Growth trend Analysis By source
6.6 Absolute $ Opportunity Analysis By source, 2024-2030
Chapter 7. Pharmaceutical Amino Acid Market – By Type
7.1 Introduction/Key Findings
7.2 Essential amino acid
7.3 Non-essential amino acid
7.4 Y-O-Y Growth trend Analysis By Type
7.5 Absolute $ Opportunity Analysis By Type, 2024-2030
Chapter 8. Pharmaceutical Amino Acid Market – By Application
8.1 Introduction/Key Findings
8.2 Health-care products
8.3 Medicine
8.4 Others
8.5 Y-O-Y Growth trend Analysis By Application
8.6 Absolute $ Opportunity Analysis By Application, 2024-2030
Chapter 9. Pharmaceutical Amino Acid Market – By Component
9.1 Introduction/Key Findings
9.2 Lysine
9.3 Glutamic acid
9.4 Valine
9.5 Leucine
9.6 Isoleucine Y-O-Y Growth trend Analysis By Component
9.7 Absolute $ Opportunity Analysis By Component, 2024-2030
Chapter 10. Pharmaceutical Amino Acid Market , By Geography – Market Size, Forecast, Trends & Insights
10.1 North America
10.1.1 By Country
10.1.1.1 U.S.A.
10.1.1.2 Canada
10.1.1.3 Mexico
10.1.1.4 By source
10.1.1.5 By Component
10.1.2 By Application
10.2 By Type
10.2.1 Countries & Segments - Market Attractiveness Analysis
10.3 Europe
10.3.1 By Country
10.3.1.1 U.K
10.3.1.2 Germany
10.3.1.3 France
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Europe
10.3.2 By source
10.3.3 By Type
10.3.4 By Application
10.3.5 By Component
10.3.6 Countries & Segments - Market Attractiveness Analysis
10.4 Asia Pacific
10.4.1 By Country
10.4.1.1 China
10.4.1.2 Japan
10.4.1.3 South Korea
10.4.1.4 India
10.4.1.5 Australia & New Zealand
10.4.1.6 Rest of Asia-Pacific
10.4.2 By source
10.4.3 By Type
10.4.4 By Application
10.4.5 By Component
10.4.6 Countries & Segments - Market Attractiveness Analysis
10.5 South America
10.5.1 By Country
10.5.1.1 Brazil
10.5.1.2 Argentina
10.5.1.3 Colombia
10.5.1.4 Chile
10.5.1.5 Rest of South America
10.5.2 By source
10.5.3 By Type
10.5.4 By Application
10.5.5 By Component
10.5.6 Countries & Segments - Market Attractiveness Analysis
10.6 Middle East & Africa
10.6.1 By Country
10.6.1.1 United Arab Emirates (UAE)
10.6.1.2 Saudi Arabia
10.6.1.3 Qatar
10.6.1.4 Israel
10.6.1.5 South Africa
10.6.1.6 Nigeria
10.6.1.7 Kenya
10.6.1.8 Egypt
10.6.1.9 Rest of MEA
10.6.2 By source
10.6.3 By Type
10.6.4 By Application
10.6.5 By Component
10.6.6 Countries & Segments - Market Attractiveness Analysis
Chapter 11. Pharmaceutical Amino Acid Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
11.1 Ajinomoto Co., Inc.
11.2 KYOWA HAKKO BIO CO., LTD.
11.3 AMINO GmbH
11.4 Bill Barr & Company
11.5 IRIS BIOTECH GMBH
11.6 BI Nutraceuticals
2850
5250
4500
1800
Frequently Asked Questions
The Pharmaceutical Amino Acid Market was valued at USD 27.5 billion in 2023.
The market is projected to grow at a CAGR of 9%.
The market is growing as a result of the rising incidence of chronic illnesses and the demand for customized treatment, developments in biotechnology and pharmaceutical production techniques rising healthcare costs, rising knowledge of the role amino acids play in managing diseases, and expanding geriatric population.
The key players are Ajinomoto Co., Inc., KYOWA HAKKO BIO CO., LTD, AMINO GmbH, Bill Barr & Company, and IRIS BIOTECH GMBH.
Several issues, such as price volatility, regulatory compliance, side effects, alternative sources, competition from replacements, and low consumer knowledge, could hinder the growth and development of the amino acid industry.